Aims: Alcohol mixed with energy drinks (AmED) is a relatively new consumption trend 2 generating increasing concern regarding potential adverse effects. Despite the political and 3 health imperative, there has been no systematic and independent synthesis of the literature to 4 determine whether AmED offers additional harms relative to alcohol. The aim of this study 5 was to review the evidence about whether co-consumption of energy drinks and alcohol, 6 relative to alcohol alone, alters: (i) physiological, psychological, cognitive, and psychomotor 7 outcomes, (ii) hazardous drinking practices, and (iii) risk-taking behaviour. 8
This article is protected by copyright. All rights reserved. laboratory studies were identified; one assessed self-reported physiological state via 100-132 point visual analogue scale intensity ratings (5) , while the other objectively assessed a limited 133 range of physiological outcomes (22) ( Table 2 ). There were no case-control or case crossover 134 studies identified comparing alcohol-and AmED-related adverse exposures reported to 135 emergency departments or poison information call centres. 
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This article is protected by copyright. All rights reserved. Table 2 approximately here*** 158 159 Similar disturbances are evident when examining other central nervous system (CNS) 160 outcomes, with higher odds of agitation and 'jolt and crash episodes' in AmED sessions (26) . 161
In contrast, retrospective studies of other physiological outcomes (e.g., dizziness, headache) 162 had equivalent odds across session type or were inconsistent across studies. However, these 163 studies may underestimate AmED outcomes: Penning, et al. this study is methodologically robust, in that a clear definition of AmED use was provided to 168 participants, and within-subject comparisons were adopted to rule out between-subject 169
variability. 170 171
In contrast with this research, the placebo-controlled double-blind experimental study 172 assessing self-reported outcomes showed equivalent odds for musculoskeletal, 173 cardiovascular, gastrointestinal, general functioning, and CNS disturbance ratings when 174 consumers ingested alcohol (0.6g/kg or 1.0g/kg) with and without ED (3.57mL/kg), with the 175 exception of increased salivation 120 minutes after AmED administration (5) . The latter 176 double-blind, placebo-controlled, within-subjects study by Ferreira, et al. (22) showed that 177
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blood pressure was significantly decreased after administration of alcohol (1.0g/kg) with ED 178 (3.57mL/kg) compared to alcohol without ED; consistent with caffeine's peak absorption 179 time (30-60 minutes) (31), this effect was only evident at the later time point (30 minutes) 180 (22). These studies are methodologically strong, in that comparison of AmED and alcohol 181 outcomes was within-subject, and blinding procedures were adopted to minimise the impact 182 of confounding variables. However, it is important to note that the ED dose administered is 183 equivalent to approximately one standard 250mL ED (80mg caffeine) per 70kg person. In 184 contrast, AmED consumers in the aforementioned cross-sectional descriptive studies report 185 typically ingesting a higher volume of ED with alcohol, with 61% of those surveyed by 186
Woolsey and colleagues (29, 30) typically consuming three or more EDs (approximately 187 240mg caffeine) with alcohol. 188
189

Psychological Outcomes 190
Self-reported psychological outcomes of AmED versus alcohol were assessed in three studies 191 of consumers' real-life drinking experiences (26-28) and one study of consumers ' 192 expectations for drinking sessions (29) (Table 3) . Again, the number and type of outcomes 193 assessed were not standardised across studies. Despite the fact that these studies adopted 
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This article is protected by copyright. All rights reserved. 203 *** Table 3 In contrast to the physiological research, there was a greater body of experimental research 215 available assessing psychological outcomes. Five double-blind placebo-controlled 216 experimental studies were identified (Table 4) ; four of these studies (6, 23, 24, 32) focused on 217 assessing stimulation and sedation via a validated measure, the Biphasic Alcohol Effects 218 Scale (33), whilst the other (34) adopted a more general measure of psychological state, the 219 Profile of Mood States (35). The former four studies partially reflect real-life drinking 220 experiences, in that participants generally reported significantly higher stimulation scores 221 after ingesting alcohol (peak mean breath alcohol concentration (BrAC) .043% to 0.89%) 222 with ED (1.82mL/kg to 3.57mL/kg) relative to alcohol alone (6, 23, 24, 32 ). However, these 223 studies did not typically identify AmED-induced reduced sedation, with equivalent odds for 224 BAES sedation scores (6, 23, 24, 32) . Mental fatigue ratings were generally equivalent (5, 225 32), with the exception of one study showing decreased ratings after AmED (23). 226
227
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These experimental studies are well designed, in that the majority involved within-subject 228 comparison of outcomes, ruling out between-subject variability. Furthermore, double-blind 229 procedures were adopted in most cases, minimising the impact of confounding variables. 230
However, these studies involved administration of a low ED dose, equivalent to one standard 231 250mL ED (80mg caffeine) per 70kg person. There has been one study using higher doses: 232
Alford, et al. (36) administered participants two alcohol doses (peak BrAC .046% and .087%) 233 across the session; following a between-subjects design, placebo or active ED (250mL; 80mg 234 caffeine) was co-administered with each alcohol dose. In contrast with previous findings, this 235 study revealed significantly lower ratings of 'clearheaded' and 'energetic' after the first dose, 236 and significantly higher subscale scores for 'mentally slow', 'clumsy', and 'drowsy' after 237 both doses, when ED was co-ingested. It should be noted that systematic between-subject 238 variability in ratings for those in the active ED condition versus those in the placebo ED 239 condition could contribute to these differences. 240 241 *** Table 4 approximately here*** 242
243
Cognitive and Motor Outcomes 244
To date, there has been little consistency in outcomes across cognitive studies; this may be 245 due to the small number of measurements for each area of interest, the various tasks adopted, 246 and the different point during the blood alcohol concentration curve at which each are 247 assessed. For example, Alford, et al. (36) reported that AmED significantly decreased 248 interference on the Stroop task, reflecting increased inhibitory control, whereas Marczinski, 249 et al. (6) found equivalent rates of inhibition failures after valid and invalid cues on the Cued 250
Go/No-Go task after AmED relative to alcohol. These discrepant methodological approaches 251 make definitive conclusions regarding the relative cognitive effects of AmED challenging. In 252 Accepted Article contrast, equivalence between AmED and alcohol administration has been consistently 253 demonstrated across studies for motor outcomes, with similar performance on fine and gross 254 motor performance regardless of whether ED was co-ingested with alcohol or not. A strength 255 of this research area is that the majority of studies investigated the effects of a similar alcohol 256 (0.65g/kg) and ED (3.57mL/kg) dose, enabling comparison based on intake. However, as 257 aforementioned, the doses administered in this context typically fell below that reported by 258 consumers in cross-sectional descriptive research. 259 *** Table 5 approximately here*** 260
261
Alcohol Intake and Priming 262
Seven studies were included that compared retrospective self-reported consumption patterns 263 of AmED versus alcohol consumers (between-subject comparison) and four studies that 264 compared AmED versus alcohol consumption patterns among AmED consumers (within-265 subject comparison: Table 6 ). While these studies typically adopted similar indices of alcohol 266 consumption with quantitative responses, a clear strength of this research area, the 267 retrospective assessment period varied from 'tonight' to 'in the last year'. The authors of one 268 paper declined the request for data (25). Only one experimental study was identified in this 269 area assessing motivation to drink following a priming dose; no studies were identified 270 assessing ad libitum alcohol consumption following priming. 271
272
Studies undertaking between-subjects comparisons consistently indicate that AmED 273 consumers report: (i) greater typical and maximum alcohol intake, (ii) more frequent alcohol 274 use, and (ii) more frequent drunk/binge sessions. These results suggest that AmED consumers 275 are riskier drinkers relative to alcohol consumers. Between-subjects field research assessing 276 event level consumption and intoxication by AmED and alcohol consumers have revealed 277 divergent outcomes: one study has shown a trend towards higher mean BrAC for AmED 278 consumers (37), whilst the other showed equivalent mean BrAC for the two consumer groups 279 (38). 280 281 *** Table 6 
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Risk-Taking 303
Two studies were identified comparing retrospective self-reported behaviour by AmED 304 versus alcohol consumers (Table 7) , one study was identified comparing AmED versus 305 alcohol consumers' engagement in alcohol-specific risk-taking (4), and one study was 306 identified comparing engagement in risk-taking by AmED and alcohol consumers after 307 ingesting the respective beverage (25); the request for data was declined for the latter study. 308
These studies typically assessed select risk-taking behaviours relating to driving and sexual 309 risk-taking, licit and illicit drug use, and physical harm, although items, and the retrospective 310 reference period, were not standardised across studies. Only two within-subject studies were 311 identified, both adopting subjective self-report measures (26, 27), as well as one study 312 examining risk-taking expectations (29) ( Table 7 ). Only one experimental study was 313 identified assessing the acute effects of AmED and alcohol on objective risk-taking. This 314 dearth of within-subjects studies, particularly those circumventing self-report issues by 315 adopting objective measures or utilising case-control/case crossover assessments of alcohol-316 related injuries reported to emergency departments, limits inferences regarding the 317 pharmacological impact of ED and alcohol co-ingestion on risk-taking. It should be noted 318 that several of the studies undertaking between-subject comparison did control for some 319 potential systematic individual differences (e.g., level of alcohol consumption, general risk-320 taking behaviour) between consumer groups in their original analyses (2, 4) . While this 321 approach does not fully address issues of between-subject variability, it does strengthen 322 inferences regarding risk-taking behaviour by AmED consumers. 323
324
Those studies undertaking between-subject comparison of general risk-taking showed 325 increased odds of general risk-taking (2) and tobacco and illicit drug use (2, 27) among 326 AmED users. Similarly, the study comparing engagement in alcohol-specific risk-taking, 327
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showed that AmED consumers reported significantly increased odds of taking and having 328 been taken advantage of sexually, being physically hurt or injured, requiring medical 329 treatment, being a passenger in a car with a driver over the legal alcohol limit and driving 330 whilst under the influence (4) . 331
332
The results of the within-consumer retrospective comparison studies directly contrast with 333 these outcomes (26, 27 
Available Evidence 359
Overall, the body of literature on AmED is typically dominated by retrospective self-report 360 studies. With the exception of the alcohol intake research, the types of items assessed, item 361 wording, and response type generally differ across studies. Furthermore, in some areas there 362 is a predominance of between-subject research, meaning that individual differences between 363 consumer groups confound conclusions regarding the effect of AmED, although several of 364 these studies controlled for some potential between-subject variability in their analyses. Few 365 experimental studies were identified, particularly in regards to studies adopting objective 366 outcome measures. Cross-sectional descriptive research provides valuable information to 367 researchers, health professionals, and policy-makers, as it reflects the 'real-world' drinking 368 experiences of consumers. However, it should be noted that the reliance on self-reported 369 drinking experience data, particularly retrospective data, introduces other potential 370 contributing psychological (e.g., expectancy), individual (e.g., trait personality), and 371 environmental (e.g., drinking environment) factors which could influence outcomes, as well 372 as methodological concerns (e.g., recall bias). In regards to assessing the direct 373 pharmacological effects of AmED versus alcohol, experimental laboratory-based research 374 provides the strongest evidence for direct attribution to the effects of the drinks, although 375
case-control and case crossover studies comparing alcohol-and AmED-related emergency 376 department and poison information call centre data could also provide valuable insight into 377
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adverse exposures and harms post-consumption (providing the co-consumption of energy 378 drinks is accurately recorded by clinical staff). Despite the increase in AmED research over 379 the past few years (68% of the reviewed articles were published between 2011 and 2013), the 380 general dearth of research in this area is surprising considering the public attention dedicated 381 to this consumption trend (41, 42) and current endeavours to determine an appropriate policy 382
response. 383 384
General Overview 385
Physiological Outcomes 386
The preliminary evidence from research assessing self-reported outcomes of AmED 387 consumption indicates potential changes to the nature of intoxication; the cross-sectional 388 descriptive within-subject studies consistently indicate that consumers are more likely to self-389 report experiencing musculoskeletal (e.g., tremors), cardiovascular (e.g., increased heart 390 rate), and CNS (e.g., agitation) disturbance after AmED. It is theorised that these outcomes 391 may be a consequence of the stimulatory effects of EDs, consistent with the common side-392 effects of caffeine overconsumption (43). Consumers also report reduced sedation-based 393 outcomes, specifically: nausea, walking difficulty, and vision difficulties. The dual effect of 394 ED co-ingestion is illustrated most clearly when examining transient speech impairment, with 395 consumers reporting increased odds of faster speech, and lower odds of slurred speech, in 396 AmED sessions. Several primary intoxication outcomes (e.g., dizziness, headache) showed 397 equivalent odds in AmED and alcohol sessions. The experimental research undertaken by 398 Ferreira and colleagues (5, 22 ) is particularly enlightening, in that it directly assessed the 399 pharmacological effects of AmED versus alcohol on objective and subjective physiological 400 outcomes in a controlled environment. Whilst this research showed little evidence of AmED-401 induced changes in physiological state relative to alcohol, the low dosing protocols adopted 402
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Hazardous Drinking 433
AmED physiological and psychological outcomes are theorised to increase the likelihood of 434 excess alcohol intake and risk-taking behaviour by decreasing sedation-based cues of 435 intoxication (5, 6), creating a 'wide-awake drunkenness' state (7). This review consistently 436 indicated that AmED consumers report more risky drinking practices than alcohol 437 consumers. However, the few studies comparing alcohol intake in AmED versus alcohol 438 sessions have provided mixed support for this hypothesis, with several revealing increased 439 intake (2, 26, 39) whilst others indicate decreased intake (27, 29) in AmED sessions. 440
Attempts to reconcile these results point predominantly to the lack of standardisation in 441 defining AmED, however it is important to note that all but one (26) of these studies focused 442 only on college student consumers, a subgroup who typically display high-risk drinking 443 practices (44). Comparison of alcohol intake following an acute AmED and alcohol priming 444 dose in a controlled setting would control for external influences. However, no experimental 445 studies examining ad-libitum alcohol consumption following an AmED or alcohol priming 446 dose were identified. The only experimental study to indirectly assess the effects of AmED 447 on alcohol consumption, via ratings of motivation to drink, showed equivalent outcomes. 448
Consequently, the hypothesis that AmED consumption increases subsequent alcohol intake 449 cannot be discounted due to the equivocal nature of the literature. 450 451
Risk-Taking 452
Accepted Article
The reviewed research consistently indicated that AmED consumers report greater risk-taking 453 behaviour relative to alcohol consumers. However, the only two cross-sectional descriptive 454 within-subject research involving self-report of risk-taking behaviour showed that AmED 455 consumers self-report less risk-taking in AmED versus alcohol sessions (26, 27) and one 456 study showed lower odds of disinhibition in AmED sessions (26). These results contradict 457 common assumptions regarding the behavioural effects of AmED (9) . One explanation may 458 be that AmED-induced increases in alertness may improve consumers' attentional capacity 459 for decision-making (26). These studies were methodologically robust, in that they adopted 460 within-subject comparison of AmED versus alcohol outcomes, ruling out between-subject 461 variability, and reflected consumers' 'real-world' drinking experiences. However, these 462 preliminary outcomes may underestimate risk-taking in AmED sessions, in that analyses did 463 not account for the relative frequency of AmED and alcohol sessions (45, 46). Only one 464 experimental study exploring risk-taking propensity was identified, contradicting common 465 assumptions regarding the behavioural effects of AmED and revealing equivalent odds of 466 risk-taking after AmED and alcohol (32), potentially a consequence of poor task sensitivity to 467 the low doses administered. No studies were identified assessing the dose-dependent effects 468 of AmED on risk-taking to determine whether interactive AmED effects on risk-taking 469 become apparent at doses similar to those ingested in real-life drinking contexts. 470
471
Limitations 472
The current evidence-base is strong in regards to the reporting of physiological and 473 psychological real-world drinking experiences following AmED versus alcohol consumption 474 for the same individuals. However, there is no data currently available as to the relative 475 clinical severity and dose threshold at which physiological and psychological changes of 476 AmED occur. While there are guidelines outlining the recommended maximum daily caffeine 477
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intake (e.g., Food Standards Australia and New Zealand (47)) to minimise adverse outcomes, 478 laboratory-based research controlling for external confounds has generally shown no 479 difference in physiological, psychological, cognitive, psychomotor, and behavioural 480 outcomes following AmED and alcohol administration. However, these studies have 481 generally investigated the effect of ED co-ingestion at a dose lower than that typically 482 ingested in real-life settings, restricting ecological validity and generalizability. In this 483 instance, case-control or case crossover studies comparing AmED-and alcohol-related 484 adverse events identified in emergency department and poison information call centre data 485 could be beneficial for the development of public health policy. circumvented by objective measurement of outcomes, typically in a laboratory-based setting. 500
While laboratory-based assessment can reduce ecological validity, the controlled 501 environment and beverage blinding can reduce the impact of these confounding variables. 502
Outcomes can be objectively assessed to eliminate potential self-report biases and within-503 subject designs control systematic individual differences. Acute dosing protocols can link 504 specific doses with changed outcomes. As aforementioned, this review revealed no 505 experimental research assessing high ED doses or the dose-dependency of ED effects when 506 co-ingested with a set alcohol dose. As such, we cannot determine whether the self-reported 507 outcomes are an accurate reflection of the pharmacological effects of AmED or a product of 508 intertwined environmental (e.g., drinking environment), psychological (e.g., expectancy 509 effects), and methodological (e.g., recall bias) factors. Whilst it will be necessary to assess 510 the effects of consumer' expectancies on AmED physiological, psychological, and 511 behavioural consequences in future research, it is important to note that the potential 512 confounding role of expectancies in past research does not render the results of these studies 513 invalid; the potential harms of AmED use may be due to a combination of pharmacological, 514 individual, and situational factors. 515
516
Another consideration when interpreting these outcomes is that omission of operationalized 517 descriptions of AmED use in some studies could leave the definition of use open to 518 participant interpretation. Lack of standardisation in defining AmED use across studies may 519 also undermine comparison of outcomes, particularly as AmED use can be differentially 520 categorised as consumption of pre-mixed beverages, hand-mixed beverages, or a combination 521 of both practices, as well as alcohol and EDs consumed in the same container or in the same 522 session (sometimes up to four hours apart). This is an important consideration as it would 523 seem plausible that consumption of both beverages in the same session but hours apart would 524 be related to different motivations of use than simultaneous consumption. In addition, a 525 limitation of survey studies is that many do not ask participants to specify the quantity of 526 energy drink units they refer to in their self-reported consumption (i.e., whether one ED unit 527
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is equivalent to 125mL, 250mL or even 500mL). While our review was restricted to studies 528 which specifically looked at EDs (as opposed to other caffeinated products), in several 529 studies no information about the composition and quantity of primary ingredients was 530 detailed in manuscripts (although it is important to note that this information may have been 531 provided to participants). As a consequence, the diverging results may be reflective of 532 differing patterns of use and beverage types across studies. 533
534
These issues also pertain to characterising the causal link between AmED consumption and 535 likelihood of excess alcohol intake and risk-taking behaviour. The general dearth of research 536 coupled with heterogeneous outcome measures used across studies has impeded the 537 construction of a strong evidence-base assessing whether AmED offers additional 538 behavioural harms relative to alcohol. This is particularly true of the few risk-taking studies 539 conducted, which have utilised measures which are difficult to compare, such as self-reported 540 sexual risk-taking and balloon popping using the BART. Furthermore, average alcohol intake 541 in AmED versus alcohol drinking sessions was not statistically controlled in the present 542 analyses when comparing retrospective self-reported behavioural outcomes of use (although 543 it should be noted that several studies controlled for alcohol consumption practices in original 544 between-subject comparisons). Given the various definitions of AmED use, and discrepant 545 outcomes in regards to alcohol intake when mixing versus consuming alcohol alone, it is 546 crucial to take into consideration level of intoxication when comparing rates of risk-taking. 547
This review consistently indicated that AmED consumers comprise a subgroup with a higher 548 predisposition towards risky behaviour. Potential state-dependent changes in behavioural 549 outcomes, coupled with a trait tendency towards risky behaviour, could place this consumer 550 group at higher risk of experiencing or causing harm. Harm reduction policies should be 551
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targeted at this group to ensure that consumers are educated regarding the potential side-552
serving size, simultaneous consumption and beverage type), consistent time frames (i.e. past 563 month) and with alcohol consumption controlled for in analyses. Whilst taking into account 564 the ethical constraints surrounding dosing in a laboratory context, it is important that future 565 experimental research is directed at characterising the profile associated with co-566 administration of alcohol with ED doses which fall below, match, and exceed maximum 567 recommended intake guidelines for policy relevance, and which reflect typical self-reported 568 intake by consumers to maximise ecological validity. 
devising matched placebo samples for double-blind experimental studies is also an 577 acknowledged difficulty in this field of research (one experimental study included in this 578 review administered placebo samples provided by industry (32)). The balance between 579 scientific rigour and integrity in AmED research requires attention, in that confidence in the 580 research design, as well as in the conduct and interpretation of outcomes, must be maximised 581 to ensure a solid, objective evidence-base. 582 583
Conclusions 584
In sum, the cross-sectional descriptive research involving within-subject comparison of 585
AmED versus alcohol outcomes consistently indicated that AmED may exert a dual effect, 586 increasing stimulation-based outcomes and reducing specific sedation-based physiological 587 outcomes relative to when alcohol is consumed without ED. While the experimental research 588 comparing the effects of AmED versus alcohol administration offered the best indication of 589 the pharmacological effects of the beverages, showing little change in 590 physiological, psychological, and behavioural intoxication state, the low doses administered 591 relative to self-reported consumer intake restricted inferences regarding 'real-life' 592 intoxication experience. The cross-sectional descriptive and experimental literature is mixed 593 as to whether these changes in the nature of intoxication translate into an increased likelihood 594 of greater alcohol intake and risk-taking behaviour. Despite the growth in AmED popularity, 595
there is a dearth of research assessing the relative effects of alcohol ingested with and without 596 ED at naturalistic consumption levels. As such, it is imperative that further research is 597 undertaken to determine the clinical severity and dose threshold at which AmED-induced 598 changes in the physiological, psychological, and behavioural nature of intoxication occur. At 599 present, the existing literature provides valuable insight into changes to the nature of 600 
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Gastrointestinal:
Stomach ache 0.77 (0.37, .685
Disruption of Functioning:
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Objective Outcomes: Note. a Note that ^ indicates within-subject comparisons for AmED-related analyses, whereas # indicates between-subject design. The outcomes reported by Penning, et al. (28) reflect between-consumer ratings of AmED versus alcohol hangover experiences when they last consumed the respective beverages, whereas outcomes reported by de Haan, et al. (27) and Peacock, et al. (26) reflect within-consumer comparison of outcomes in the last year and last six months respectively in AmED versus alcohol drinking sessions; the former study involved dichotomous responses (yes/no) while in the latter study response options were grouped as outcome present ('half the time', 'most of the time', 'all of the time') or outcome absent ('none of the time', 'less than half the time'). Outcomes reported by Woolsey, et al. (29) also comprise within-consumer comparison, except AmED consumers were asked to report their expected behaviour in future AmED and alcohol drinking sessions, endorsing the likelihood of the outcome on a 4-point scale from 1 'disagree' to 4 'agree'. b The outcomes reported by Ferreira, et al. (5) reflect within-subject comparison of 100-mm visual-analogue change from baseline ratings after consuming 0.6g/kg or 1.0g/kg alcohol with or without 3.57mL/kg ED.
c The outcomes reported by Ferreira, et al. (22) represent blood pressure (medium beats per minute) recorded using a semiautomatic sphygmomanometer after administration of 1.0g/kg alcohol with 3.57mL/kg ED.
d Note that these times represent the time reference period for reporting (self-report of drinking experiences) or the minutes between beverage administration and subjective outcome administration (experimental research); note that those in italics only provided the time for commencing the test battery as a whole.
e Odds ratios were calculated using the means and standard deviations or percentages/counts provided in-text, with the exception of those indicated by a ^, which were calculated using the means and t-statistic. An odds ratio of 1 indicates the event is equiprobable (or that the means are similar) for each consumer/in each session, > 1 indicates the event is more likely to occur (or that a higher mean was recorded) for AmED versus alcohol consumers/in AmED sessions relative to alcohol sessions, and <1 indicates the event is less likely to occur (or that a lower mean was recorded) for AmED versus alcohol consumers/in AmED sessions relative to alcohol sessions. ~Note that for the items 'nausea' and 'vomiting', de Haan, et al. (27) grouped the two outcomes as one item ('I have felt very sick to my stomach or thrown up after drinking'), whilst Peacock, et al. (26) limited assessed these two outcomes separately. OR: odds ratio; 95% CI: 95% confidence interval. A 'jolt and crash episode' refers to a sudden increase in energy followed by a sudden drop in energy. OR: odds ratio; 95% CI: 95% confidence interval; AmED: alcohol mixed with energy drink.
Novelty-Seeking Mood:
Daring 
Note.
a Note that ^ indicates within-subject comparisons for AmED-related analyses, whereas # indicates between-subject design. The outcomes reported by Penning et al. reflect between-consumer ratings of AmED versus alcohol hangover experiences when they last consumed the respective beverages, whereas outcomes reported by de Haan, et al. b Note that these times represent the time reference period for reporting.
c Odds ratios were calculated using the means and standard deviations or percentages/counts provided in-text, with the exception of those indicated by a ^, which were calculated using the means and t-statistic. An odds ratio of 1 indicates the event is equiprobable (or that the means are similar) for each consumer/in each session, > 1 indicates the event is more likely to occur (or that a higher mean was recorded) for AmED versus alcohol consumers/in AmED sessions relative to alcohol sessions, and <1 indicates the event is less likely to occur (or that a lower mean was recorded) for AmED versus alcohol consumers/in AmED sessions relative to alcohol sessions. OR: odds ratio; 95% CI: 95% confidence interval; AmED: alcohol mixed with energy drink. 
Note. a Note that ^ indicates within-subject comparisons for AmED-related analyses, whereas # indicates between-subject design. The outcomes reported by: (i) Alford, et al. (36) reflect between-subject comparison of change from baseline ratings after drink 1 (.046% BrAC) and drink 2 (.087% BrAC) of alcohol with or without 250mL ED, (ii) Ferreira, et al. 
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comparison of change from baseline ratings after consuming 0.50g/kg alcohol with or without 3.57mL/kg ED. All items were rated on 100-mm visual analogue scale (anchors: 0 'not at all' to 100 'very much') with the exception of: (i) stimulation and sedation, assessed using the Biphasic Alcohol Effects Scale (BAES), where subscale scores are derived following 11-point Likert ratings of 7 stimulant and 7 sedation adjectives, and (ii) outcomes reported by Alford, et al. (36) , who used 100-mm visual analogue scales from the Profile of Mood States (35) representing bipolar adjective pairs of clearheaded-muzzy, clumsy-wellcoordinated, energetic-lethargic, drowsy-alert, and mentally slow-quick witted.
b Note that these times represent the minutes between beverage administration and subjective outcome administration; those in italics only provided the time for commencing the test battery as a whole.
c Odds ratios were calculated using the means and standard deviations or percentages/counts provided in-text, with the exception of those indicated by a ^, which were calculated using the means and t-statistic. An odds ratio of 1 indicates the event is equiprobable (or that the means are similar) for each consumer/in each session, > 1 indicates the event is more likely to occur (or that a higher mean was recorded) for AmED versus alcohol consumers/in AmED sessions relative to alcohol sessions, and <1 indicates the event is less likely to occur (or that a lower mean was recorded) for AmED versus alcohol consumers/in AmED sessions relative to alcohol sessions. # indicates that the data was not requested from the author. OR: odds ratio; 95% CI: 95% confidence interval; AmED: alcohol mixed with energy drink.
This article is protected by copyright. All rights reserved. Note. a Note that ^ indicates within-subject comparisons for AmED-related analyses, whereas # indicates between-subject design. The outcomes reported by: (i) Alford, et al. (36) reflect between-subject comparison of the change from baseline in performance outcomes on the a critical flicker fusion threshold task, choice reaction time task, word memory task, and Stroop cognitive interference task after drink 1 (.046% BrAC) and drink 2 (.087% BrAC) of alcohol with or without 250mL ED, (ii) Ferreira, et al. (5) reflect within-subject comparison of outcomes on the PSS CogReHab 95® and Grooved Pegboard test after consuming 0.6g/kg or 1.0g/kg alcohol with or without 3.57mL/kg ED, (iii) Marczinski, et al. (6) reflect between-subject comparison of the change from baseline in performance outcomes after 0.65g/kg alcohol with or without 3.57mL/kg ED after valid and invalid cued performance on a Cued Go/No-Go Task, and (iv) Marczinski, et al. (23) reflect within-subject comparison of outcomes on a Psychological Refractory Period task and Purdue Pegboard task after 0.65g/kg alcohol with or without 3.57mL/kg ED.
b Note that these times represent the minutes between beverage administration and test administration; note that those in italics only provided the time for commencing the test battery as a whole.
c Odds ratios were calculated using the means and standard deviations or percentages/counts provided in-text, with the exception of those indicated by a ^, which were calculated using the means and t-statistic. An odds ratio of 1 indicates the event is equiprobable (or that the means are similar) for each consumer/in each session, > 1 indicates the event is more likely to occur (or that a higher mean was recorded) for AmED versus alcohol consumers/in AmED sessions relative to alcohol sessions, and <1 indicates the event is less likely to occur (or that a lower mean was recorded) for AmED versus alcohol consumers/in AmED sessions relative to alcohol sessions. OR: odds ratio; 95% CI: 95% confidence interval; AmED: alcohol mixed with energy drink.
This article is protected by copyright. All rights reserved. b Those studies indicated with a ^ asked participants reported the number of drunk days in a typical week. Note also that Brache and Stockwell (2) asked participants to report the number of days 'intoxicated' while de Haan, et al. (27) and O'Brien, et al. (4) asked participants to report the number of 'drunk' days.
c Odds ratios were calculated using the means and standard deviations or percentages/counts provided in-text, with the exception of those indicated by a *, which were calculated using the means and t-statistic. An odds ratio of 1 indicates the event is equiprobable (or that the means are similar) for each consumer/in each session, > 1 indicates the event is more likely to occur (or that a higher mean was recorded) for AmED versus alcohol consumers/in AmED sessions relative to alcohol sessions, and <1 indicates the event is less likely to occur (or that a lower mean was recorded) for AmED versus alcohol consumers/in AmED sessions relative to alcohol sessions. OR: odds ratio; 95% CI: 95% confidence interval; AmED: alcohol mixed with energy drink.
